HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$27.72
-0.09 (-0.32%)
Performance
1D
—
1W
—
1M
—
3M
-27.30%
6M
+0.29%
1Y
-16.53%
YTD
-25.84%
Open$27.90
Previous Close$27.81
Day High$27.99
Day Low$27.51
52W High$40.87
52W Low$25.52
Volume—
Avg Volume624.7K
Market Cap1.61B
P/E Ratio10.14
EPS$2.71
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.42
Below
SMA 200
$34.21
Below
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+237.4% upside
Current
$27.72
$27.72
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 864.22M | 687.86M | 502.35M |
| Net Income | 157.91M | 113.12M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 230.50M | 174.29M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |